GRI Bio, Inc. insider trading

Every open-market purchase and sale by GRI Bio, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No open-market insider trades reported in the last five years.

Does following GRI Bio, Inc.’s insiders pay?

From May 27, 2021 to June 4, 2021, 2 insiders reported 2 open-market purchases and 0 sales not made under a pre-set plan in GRI Bio, Inc.

GRI Bio, Inc.: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	Sales	12 months after their sales	Latest report
Kelly Leanne	Chief Financial Officer	1	—	—	0	—	June 4, 2021
Payne Joseph E	Director	1	—	—	0	—	May 27, 2021

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded GRI Bio, Inc.

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of GRI Bio, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 1 buying crowd with six months of prices, it averaged −0.9% against the index. One company's history is too short to judge by; the test across every company is the better guide.

Month	Crowd	3 months on, vs S&P 500	6 months	12 months
June 30, 2021	2 buying	+18.4%	−0.9%	−77.6%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

← Back to GRI Bio, Inc. · Funds · Politicians